Honoring the Heritage, Embracing the Future: Happy Singapore National Day!
Wishing you good health and a prosperous lunar new year!
Wishing you good health and a prosperous lunar new year!
EVŌQ Nano CEO Shaun Rothwell Discusses Advanced Antimicrobial Solution EVQ-218 and Its Impact on AMR
Bio interaction | News | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 06 Nov, 2024
In an insightful interview with BioSpectrum Asia, Shaun Rothwell, CEO of EVŌQ Nano, reveals the transformative potentia...Read more
Bio interaction | News | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 14 Oct, 2024
In a candid conversation with Ankit Kankar from BioSpectrum Asia, Dr. Boro Dropulić, Executive Director of Caring Cross...Read more
mRNA as novel active ingredient – PlasmidFactory providing the template for tomorrow’s vaccines
Bio interaction | News | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 02 Sep, 2024
Q: The usage of messenger RNA (mRNA) as novel active ingredient has attracted public attention in recent years, ...Read more
Pierre-Alain Ruffieux Joins Cytiva as COO, Sets Sights on Asia Pacific Growth
Bio interaction | Opinion | By Ankit Kankar | ankit.kankar@mmactiv.com | 2 Comment | 04 Jul, 2024
On July 1, 2024, Cytiva significantly bolstered its leadership team by appointing Pierre-Alain Ruffieux as Chief...Read more
Importance of HPV Testing and Genotyping in Cervical Cancer Prevention
Bio interaction | Opinion | 3 Comment | 02 May, 2023
Dr. Mohd Azizuddin bin Mohd Yussof, CT (IAC), Bsc. (Biomedical), MHealthSc. (Biomedical), PhD (Pathology) is the Directo...Read more
Driving healthcare digitization on integrated platforms to optimize care value chain
Bio interaction | Opinion | By Hithaishi C Bhaskar | 3 Comment | 23 Mar, 2023
Growing trends in healthcare digitalization are continuously transforming execution and practices in the ...Read more
Elevating Life science industry standards through the implementation of quality practices
Bio interaction | Analysis | 2 Comment | 10 Mar, 2023
Lifescience Laboratory workflows, products and services are complex and can be difficult to manage due to long and strin...Read more
Taking a patient-centric approach to value-based care in APAC
Bio interaction | Analysis | By Tim Morris, Commercial Portfolio and Partnership Director for Elsevier | 2 Comment | 10 Mar, 2023
The value-based care model is gaining momentum in the healthcare industry, and it is not hard to see why. After al...Read more
Integrated Health Corridors can deliver quality healthcare across emerging markets
Bio interaction | Analysis | 2 Comment | 09 Feb, 2023
Accessibility to quality healthcare is commonly regarded as a fundamental human right for every person. This is outlined...Read more
Singapore is beginning to see benefits of investing in technological aspect of cancer treatment
Bio interaction | Opinion | By Chew Huat Seng, Managing Director, Hitachi Asia, Malaysia | 5 Comment | 06 Feb, 2023
Medicine and technology have made tremendous strides toward defeating one of the deadliest diseases of the world, despit...Read more
VALUE is the Trending Word of 2023
Bio interaction | Opinion | By Steve Peretz, Group Director (Health Experience and Product Strategy), Appnovation, AMER | 0 Comment | 06 Feb, 2023
The last two years saw a significant leap toward patient-centricity in the pharmaceutical space. In 2023, that trend wil...Read more
Bio interaction | Influencers | 6 Comment | 06 Feb, 2023
What are the barriers to access that are impacting patient outcomes in managing antimicrobial resistance? Why do they ...Read more
Bio interaction | Opinion | By Hithaishi C Bhaksar | 5 Comment | 16 Jan, 2023
How crucial is the adaptation of next-generation TCR cell therapies for diagnostic and prophylactic purposes? TCR cell ...Read more
Bio interaction | Opinion | By Hithaishi C Bhaskar | 5 Comment | 16 Jan, 2023
Why does multiple sclerosis (MS) deserve attention and investment in APAC for the development of novel treatments? ...Read more
"Innovations that serve a purpose, paired with a good go-to-market strategy are attractive for VCs"
Bio interaction | Opinion | By Hithaishi C Bhaskar | 3 Comment | 06 Jan, 2023
In 2016, the Singapore government committed to a S$4 billion budget to drive research and commercialisation activities i...Read more
"Crovalimab could potentially become the first global drug originating from Singapore"
Bio interaction | Opinion | By Hithaishi C Bhaskar | 3 Comment | 06 Jan, 2023
Japanese headquartered Chugai Pharmaceutical has already developed world-class technologies for antibody engineeri...Read more
Propelling Genomic Research and Public Health with Future-Proof Digital Infrastructure
Bio interaction | Analysis | 4 Comment | 07 Dec, 2022
Digital transformation in healthcare has been at breakneck speed since the outbreak of the COVID-19 pandemic. It took ju...Read more
Effective policy design improves healthcare outcomes while containing costs
Bio interaction | Opinion | By Hithaishi C Bhaskar | 6 Comment | 06 Dec, 2022
MiyaHealth, a Singapore based health technology company is transforming this space, to create a much needed data reposit...Read more
1 North Bridge Road,
#08-08 High Street Centre,
Singapore 179094
Email : communications@biospectrumasia.com
+65 90150305
